Shenzhen Kangtai Biological Products Co.,Ltd.(300601),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

300601 Shenzhen Kangtai Biological Products Co.,Ltd.

Closed 12-12 15:00:00

15.24

+0.00

0.00%

High15.35	Low15.15	Vol7.71M
Open15.27	D1 Closing15.24	Amplitude1.31%
Mkt Cap17.02B	Tradable Cap13.72B	Total Shares1.12B
T/O118.00M	T/O Rate0.86%	Tradable Shares900.00M
P/B1.87	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"300601","market":"SZ","secType":"STK","nameCN":"Shenzhen Kangtai Biological Products Co.,Ltd.","latestPrice":15.24,"timestamp":1765522998000,"preClose":15.24,"halted":0,"volume":7708575,"delay":0,"changeRate":0,"floatShares":900000000,"shares":1117000000,"eps":-0.0898,"marketStatus":"Closed","change":0,"latestTime":"12-12 15:00:00","open":15.27,"high":15.35,"low":15.15,"amount":118000000,"amplitude":0.0131,"askPrice":15.25,"askSize":10,"bidPrice":15.24,"bidSize":119,"shortable":0,"etf":0,"ttmEps":-0.0898,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":15.24,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":16.76,"lowLimit":13.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1116929300,"isCdr":false,"pbRate":1.87,"roa":"--","roe":"0.51%","epsLYR":0.18,"committee":0.37845,"marketValue":17022000000,"turnoverRate":0.0086,"status":2,"floatMarketCap":13722000000},"requestUrl":"/m/hq/s/300601/tweets","defaultTab":"tweets","newsList":[{"id":"1103891489","title":"Shenzhen Kangtai Biological Products Co.,Ltd. (300601.SZ) Signs License Termination Agreement with AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1103891489","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103891489?lang=en_us&edition=fundamental","pubTime":"2025-09-30 16:15","pubTimestamp":1759220143,"startTime":"0","endTime":"0","summary":"Shenzhen Kangtai Biological Products Co.,Ltd. (300601.SZ) announced that on August 20, 2020, the company entered into a License Agreement with AstraZeneca UK Limited (referred to as \"AstraZeneca\")....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2417539215.USD","AZN","LU1829250122.USD","LU2236285917.USD","300601","BK0046","BK0201","LU0320765992.SGD","LU2456880835.USD","BK4568","LU2462157665.USD","LU0109394709.USD","LU0889565916.HKD","BK0239","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"1150289898","title":"Net Profit Plunges 77%! When Will Shenzhen Kangtai Biological Products Co.,Ltd. See a Turnaround?","url":"https://stock-news.laohu8.com/highlight/detail?id=1150289898","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150289898?lang=en_us&edition=fundamental","pubTime":"2025-09-26 11:32","pubTimestamp":1758857533,"startTime":"0","endTime":"0","summary":"The vaccine industry is awaiting an opportunity, a turning point. For all vaccine leaders, the previous logic of domestic substitution is being disproven, and innovation is the hope for the future....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300601","BK0046","BK0201","BK0239"],"gpt_icon":0},{"id":"2570061107","title":"Shenzhen Kangtai Biological Products Gets China Nod for Flu Jab","url":"https://stock-news.laohu8.com/highlight/detail?id=2570061107","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570061107?lang=en_us&edition=fundamental","pubTime":"2025-09-25 16:05","pubTimestamp":1758787546,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved Shenzhen Kangtai Biological Products  influenza virus split vaccine, according to a Wednesday filing with the Shenzhen bourse.Shares fell 1% at the close of trading on Thursday.The vaccine is indicated for use in patients aged three years and above, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0046","BK0239","BK0201","300601"],"gpt_icon":0},{"id":"1150714815","title":"Shenzhen Kangtai Biological Products Co.,Ltd. (300601.SZ): Market Authorization Application for Trivalent Influenza Virus Split Vaccine Receives Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1150714815","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150714815?lang=en_us&edition=fundamental","pubTime":"2025-09-24 18:06","pubTimestamp":1758708379,"startTime":"0","endTime":"0","summary":"Shenzhen Kangtai Biological Products Co.,Ltd. (300601.SZ) announced that the market authorization application for its self-developed influenza virus split vaccine has recently received an \"Acceptance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159646","BK0239","BK0201","BK0046","300601"],"gpt_icon":0},{"id":"1157767507","title":"Shenzhen Kangtai Biological Products Receives Drug Registration Certificate for Sabin Strain Polio Inactivated Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1157767507","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157767507?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:38","pubTimestamp":1757932702,"startTime":"0","endTime":"0","summary":"Shenzhen Kangtai Biological Products Co.,Ltd. (300601.SZ) announced that its wholly-owned subsidiary, Beijing Minhai Biotechnology Co., Ltd., has received a Drug Registration Certificate issued by...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300601","BK0239","BK0201","BK0046"],"gpt_icon":0},{"id":"1124536154","title":"Shenzhen Kangtai Biological Products Faces Revenue Growth Without Profit Increase Dilemma: Net Profit Plunges 77%, Core Products Across-the-Board Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1124536154","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124536154?lang=en_us&edition=fundamental","pubTime":"2025-09-11 16:50","pubTimestamp":1757580649,"startTime":"0","endTime":"0","summary":"Recently, Shenzhen Kangtai Biological Products Co.,Ltd. released its 2025 interim results. According to the financial data, the company achieved operating revenue of 1.392 billion yuan in the first...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0201","BK0239","BK0046","300601"],"gpt_icon":0},{"id":"2561627424","title":"Shenzhen Kangtai Biological Products' Attributable Profit Plunges 77% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2561627424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561627424?lang=en_us&edition=fundamental","pubTime":"2025-08-22 16:30","pubTimestamp":1755851403,"startTime":"0","endTime":"0","summary":"Shenzhen Kangtai Biological Products'  attributable profit fell 77% to 37.5 million yuan in the first half from 165.3 million yuan in the year-ago period, according to a Friday filing with the Shenzhen bourse.Earnings per share at the vaccine manufacturer plunged 80% to 0.03 yuan from 0.15 yuan in the prior-year period.Operating income increased 16% to 1.39 billion yuan from 1.20 billion yuan in the year-ago period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300601","BK0239","BK0201","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-02-07","address":"广东省深圳市南山区粤海街道科技园社区科发路222号康泰集团大厦","stockEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.1256},{"period":"3month","weight":-0.1762},{"period":"6month","weight":0.0489},{"period":"1year","weight":-0.1988},{"period":"ytd","weight":-0.1058}],"companyName":"深圳康泰生物制品股份有限公司","boardCode":"AI0027","perCapita":"14196股","boardName":"医药制造业","registeredCapital":"111692万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　深圳康泰生物制品股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是13价肺炎球菌多糖结合疫苗、无细胞百白破b型流感嗜血杆菌联合疫苗（四联苗）、冻干人用狂犬病疫苗（人二倍体细胞）、23价肺炎球菌多糖疫苗、重组乙型肝炎疫苗(酿酒酵母)、b型流感嗜血杆菌结合疫苗、吸附无细胞百白破联合疫苗、水痘减毒活疫苗。","serverTime":1765725661602,"listedPrice":3.29,"stockholders":"63422人(较上一季度增加3.15%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shenzhen Kangtai Biological Products Co.,Ltd.(300601),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shenzhen Kangtai Biological Products Co.,Ltd.(300601) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shenzhen Kangtai Biological Products Co.,Ltd.,300601,Shenzhen Kangtai Biological Products Co.,Ltd.股票,Shenzhen Kangtai Biological Products Co.,Ltd.股票老虎,Shenzhen Kangtai Biological Products Co.,Ltd.股票老虎国际,Shenzhen Kangtai Biological Products Co.,Ltd.行情,Shenzhen Kangtai Biological Products Co.,Ltd.股票行情,Shenzhen Kangtai Biological Products Co.,Ltd.股价,Shenzhen Kangtai Biological Products Co.,Ltd.股市,Shenzhen Kangtai Biological Products Co.,Ltd.股票价格,Shenzhen Kangtai Biological Products Co.,Ltd.股票交易,Shenzhen Kangtai Biological Products Co.,Ltd.股票购买,Shenzhen Kangtai Biological Products Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shenzhen Kangtai Biological Products Co.,Ltd.(300601),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shenzhen Kangtai Biological Products Co.,Ltd.(300601) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction